|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of BioXcel Therapeutics (NASDAQ: BTAI) through any online brokerage.
The latest price target for BioXcel Therapeutics (NASDAQ: BTAI) was reported by HC Wainwright & Co. on June 28, 2021. The analyst firm set a price target for 140.00 expecting BTAI to rise to within 12 months (a possible 432.97% upside). 14 analyst firms have reported ratings in the last year.
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $26.268 last updated Today at 6:49:39 PM.
There are no upcoming dividends for BioXcel Therapeutics.
There is no upcoming split for BioXcel Therapeutics.
BioXcel Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.